Gaëlle Quéreux Selected Research

Gaëlle Quéreux Research Topics

Disease

18	Melanoma (Melanoma, Malignant) 10/2023 - 05/2008
6	Neoplasms (Cancer) 04/2018 - 12/2009
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2022 - 01/2007
4	Lymphoma (Lymphomas) 09/2011 - 01/2007
3	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2011
2	Parapsoriasis 04/2009 - 01/2007
1	Pemphigoid Gestationis (Herpes Gestationis) 06/2023
1	Blister (Bulla) 06/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021
1	Eosinophilia 11/2020
1	Pruritus (Itching) 11/2020
1	Drug Hypersensitivity Syndrome 02/2019
1	Darier Disease (Darier's Disease) 01/2019
1	Pyoderma Gangrenosum 04/2018
1	Hemangiosarcoma (Angiosarcoma) 11/2016
1	Crohn Disease (Crohn's Disease) 10/2016
1	Basal Cell Carcinoma (Rodent Ulcer) 04/2016
1	Weight Loss (Weight Reduction) 04/2016
1	Dysgeusia (Parageusia) 04/2016
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2015
1	Skin Neoplasms (Skin Cancer) 09/2013
1	Carcinoma (Carcinomatosis) 05/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2010
1	Mycosis Fungoides 01/2007

Drug/Important Bio-Agent (IBA)

3	Circulating Tumor DNAIBA 04/2021 - 10/2016
3	Interleukin-2 (IL2)IBA 08/2020 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 04/2018 - 05/2011
2	NivolumabIBA 10/2023 - 04/2018
2	VemurafenibIBA 02/2019 - 05/2014
2	ParaffinIBA 12/2017 - 04/2009
2	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 10/2016
2	Bexarotene (LGD1069)FDA Link 09/2013 - 08/2010
1	bempegaldesleukinIBA 10/2023
1	AntibodiesIBA 06/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	mogamulizumabIBA 03/2022
1	cemiplimabIBA 07/2021
1	AutoantibodiesIBA 11/2020
1	InterferonsIBA 08/2020
1	Immune Checkpoint InhibitorsIBA 07/2020
1	cobimetinibIBA 02/2019
1	Alitretinoin FDA Link 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	trametinibIBA 04/2018
1	dabrafenibIBA 04/2018
1	Programmed Cell Death 1 ReceptorIBA 04/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2018
1	Formaldehyde (Formol)FDA Link 12/2017
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 04/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2016
1	Propranolol (Inderal)FDA LinkGeneric 11/2016
1	Infliximab (Remicade)FDA Link 10/2016
1	HhAntag691IBA 04/2016
1	Vorinostat FDA Link 01/2015
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2012
1	CD58 Antigens (LFA-3)IBA 01/2012
1	fotemustine (Muphoran)IBA 12/2011
1	Rituximab (Mabthera)FDA Link 09/2011
1	RNA (Ribonucleic Acid)IBA 05/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2010
1	MART-1 AntigenIBA 12/2009
1	Transcription Factor 3IBA 05/2008
1	AntigensIBA 01/2007

Therapy/Procedure

7	Therapeutics 10/2023 - 08/2010
3	Immunotherapy 04/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 07/2020 - 12/2011
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Emergency Treatment 12/2017
1	Transplantation 04/2017